-
$32 M Capital One Overdraft Deal OK'd By Judge
Posted By Golomb & Honik
||
22-May-2015
Law360, New York (May 22, 2015, 6:15 PM ET) — A Florida judge on Friday signed off on an almost $31.8 million settlement between Capital One Bank NA and plaintiffs in multidistrict litigation over allegedly deceptive overdraft fees, saying that the recovery amount is extremely reasonable given the risks faced by the plaintiffs. U.S. District Judge James Lawrence King granted final approval ...
Continue Reading
-
Improper Monitoring and Birth Injury
Posted By Golomb & Honik
||
12-May-2015
The United States boasts one of the most advanced medical systems in the world. It is the obvious expectation of mothers that their labor and delivery will be handled with the care and attention our medical standards demand. But all too often, incompetent or negligent staff allow delivering mothers to go without proper monitoring, resulting in thousands of easily avoidable birth injuries every ...
Continue Reading
-
Zofran Linked to Birth Defects by Four Studies
Posted By Golomb & Honik
||
11-May-2015
The drug Zofran (Ondansetron) has been linked by at least four studies to an increased risk of birth defects. Zofran was approved by the FDA in 1991 only for the treatment of nausea experienced by chemotherapy and radiation patients, as well as for patients who experienced nausea following a surgical procedure. Zofran officials, however, touted the drug to doctors as a cure for severe morning ...
Continue Reading
-
Blue Bell Recalls All Products Due to Listeria
Posted By Golomb & Honik
||
11-May-2015
The recent announcement that Blue Bell would recall all its ice cream products from every Blue Bell manufacturing facility may have raised more questions than it has answered. Blue Bell CEO and President, Paul Kruse, stated the best way to do the “right thing” was to remove all products from the market until it is determined they are safe for consumer consumption. The products in ...
Continue Reading
-
Plaintiffs Say Shire Withholding Docs In Pay-For-Delay Suit
Posted By Golomb & Honik, P.C.
||
5-May-2015
By Kelly Knaub Law360, New York (April 20, 2015, 4:57 PM ET) — Plaintiffs in a pay-for-delay putative class action against Shire U.S. Inc. over attention deficit hyperactivity disorder drug Adderal XR asked a Florida federal judge to order the company to turn over certain documents, saying the materials aren’t privileged as Shire claims. Attorneys for plaintiffs told Florida's ...
Continue Reading
5 results found. Viewing page 1 of 1.